These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 25137290)

  • 1. A multimeric MR-optical contrast agent for multimodal imaging.
    Harrison VS; Carney CE; Macrenaris KW; Meade TJ
    Chem Commun (Camb); 2014 Oct; 50(78):11469-71. PubMed ID: 25137290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimeric Near IR-MR Contrast Agent for Multimodal In Vivo Imaging.
    Harrison VS; Carney CE; MacRenaris KW; Waters EA; Meade TJ
    J Am Chem Soc; 2015 Jul; 137(28):9108-16. PubMed ID: 26083313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multimeric MRI contrast agent based on a closo-borane scaffold bearing modified AAZTA chelates on the periphery.
    Chakravarty S; Sarma SJ; Goswami LN; Cai QY; Shapiro EM; Hawthorne MF; Ma L
    Chem Commun (Camb); 2019 Oct; 55(82):12348-12351. PubMed ID: 31559401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Facile Synthesis of Gadolinium Chelate-Conjugated Polymer Nanoparticles for Fluorescence/Magnetic Resonance Dual-Modal Imaging.
    Pan Y; Chen W; Yang J; Zheng J; Yang M; Yi C
    Anal Chem; 2018 Feb; 90(3):1992-2000. PubMed ID: 29293314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective anchoring of Gd(III) chelates on the external surface of organo-modified mesoporous silica nanoparticles: a new chemical strategy to enhance relaxivity.
    Carniato F; Tei L; Arrais A; Marchese L; Botta M
    Chemistry; 2013 Jan; 19(4):1421-8. PubMed ID: 23233428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and characterization of new porphyrazine-Gd(III) conjugates as multimodal MR contrast agents.
    Song Y; Zong H; Trivedi ER; Vesper BJ; Waters EA; Barrett AG; Radosevich JA; Hoffman BM; Meade TJ
    Bioconjug Chem; 2010 Dec; 21(12):2267-75. PubMed ID: 21062033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tris(pyrone) chelates of Gd(III) as high solubility MRI-CA.
    Puerta DT; Botta M; Jocher CJ; Werner EJ; Avedano S; Raymond KN; Cohen SM
    J Am Chem Soc; 2006 Feb; 128(7):2222-3. PubMed ID: 16478170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AAZTA-based bifunctional chelating agents for the synthesis of multimeric/dendrimeric MRI contrast agents.
    Gugliotta G; Botta M; Tei L
    Org Biomol Chem; 2010 Oct; 8(20):4569-74. PubMed ID: 20740241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gd(DOTAla): a single amino acid Gd-complex as a modular tool for high relaxivity MR contrast agent development.
    Boros E; Polasek M; Zhang Z; Caravan P
    J Am Chem Soc; 2012 Dec; 134(48):19858-68. PubMed ID: 23157602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A high-performance imaging probe with NIR luminescence and synergistically enhanced T1-T2 relaxivity for in vivo hepatic tumor targeting and multimodal imaging.
    Liu J; Li Z; Yang X; Liu W; Wang B; Zhu Y; Mu K; Zhu W
    Chem Commun (Camb); 2015 Sep; 51(69):13369-72. PubMed ID: 26207340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide targeted tripod macrocyclic Gd(III) chelates for cancer molecular MRI.
    Zhou Z; Wu X; Kresak A; Griswold M; Lu ZR
    Biomaterials; 2013 Oct; 34(31):7683-93. PubMed ID: 23863450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioresponsive, cell-penetrating, and multimeric MR contrast agents.
    Major JL; Meade TJ
    Acc Chem Res; 2009 Jul; 42(7):893-903. PubMed ID: 19537782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving T₁ and T₂ magnetic resonance imaging contrast agents through the conjugation of an esteramide dendrimer to high-water-coordination Gd(III) hydroxypyridinone complexes.
    Klemm PJ; Floyd WC; Smiles DE; Fréchet JM; Raymond KN
    Contrast Media Mol Imaging; 2012; 7(1):95-9. PubMed ID: 22344885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of d-f coordination polymer nanoparticles and their application in phosphorescence and magnetic resonance imaging.
    Zhou Z; Li D; Yang H; Zhu Y; Yang S
    Dalton Trans; 2011 Nov; 40(44):11941-4. PubMed ID: 21976130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multimodal, β-amyloid-targeted contrast agent.
    Vithanarachchi SM; Allen MJ
    Chem Commun (Camb); 2013 May; 49(39):4148-50. PubMed ID: 23139935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanodiscs as a Modular Platform for Multimodal MR-Optical Imaging.
    Carney CE; Lenov IL; Baker CJ; MacRenaris KW; Eckermann AL; Sligar SG; Meade TJ
    Bioconjug Chem; 2015 May; 26(5):899-905. PubMed ID: 25830565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CePO4:Tb,Gd hollow nanospheres as peroxidase mimic and magnetic-fluorescent imaging agent.
    Wang W; Jiang X; Chen K
    Chem Commun (Camb); 2012 Jul; 48(54):6839-41. PubMed ID: 22648397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gd-complexes of macrocyclic DTPA conjugates of 1,1'-bis(amino)ferrocenes as high relaxivity MRI blood-pool contrast agents (BPCAs).
    Kim HK; Park JA; Kim KM; Nasiruzzaman SM; Kang DS; Lee J; Chang Y; Kim TJ
    Chem Commun (Camb); 2010 Nov; 46(44):8442-4. PubMed ID: 20886175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of intravascular contrast agents for MRI using gadolinium chelates.
    Kittigowittana K; Yang CT; Cheah WC; Chuang KH; Tuang CY; Chang YT; Golay X; Bates RW
    ChemMedChem; 2011 May; 6(5):781-7. PubMed ID: 21433294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gd (III) complex conjugate of low-molecular-weight chitosan as a contrast agent for magnetic resonance/fluorescence dual-modal imaging.
    Huang Y; Boamah PO; Gong J; Zhang Q; Hua M; Ye Y
    Carbohydr Polym; 2016 Jun; 143():288-95. PubMed ID: 27083371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.